RESEARCH-USE BIOSIMILAR ANTIBODY
Melrilimab
Monoclonal antibody · IgG2
Melrilimab (GSK 3772847; CNTO-7160) is a humanized IgG2σ monoclonal antibody that targets the IL-33 receptor ST2 and blocks the IL-33/ST2 signaling pathway by binding to the ST2 protein. Melrilimab is applicable to research related to asthma and atopic dermatitis.
TARGETST2
YMonoclonal antibody
CATALOGSC-BS-382
CATALOG NUMBERSC-BS-382
MOLECULAR WEIGHTApprox. 145.2 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Melrilimab (GSK 3772847; CNTO-7160) is a humanized IgG2σ monoclonal antibody that targets the IL-33 receptor ST2 and blocks the IL-33/ST2 signaling pathway by binding to the ST2 protein. Melrilimab is applicable to research related to asthma and atopic dermatitis.
Melrilimab is a recombinant research-use antibody directed against ST2.